Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns
- 1 January 1997
- journal article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 16 (1) , 62-73
- https://doi.org/10.1023/a:1006564002679
Abstract
Expression of proteolytic parameters of the urokinase-type plasminogen activator (uPA) system [uPA receptor (uPA-R), plasminogen activator inhibitor (PAI)-1] has been proven to be an independent...Keywords
This publication has 37 references indexed in Scilit:
- α2-Macroglobulin is mainly produced by cancer cells and not by hepatocytes in rats with colon carcinoma metastases in liverHepatology, 1996
- Receptor‐mediated endocytosis of plasminogen activators and activator/inhibitor complexesFEBS Letters, 1994
- Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane.1994
- Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma.1994
- Structure and function of the urokinase receptorBlood Coagulation & Fibrinolysis, 1993
- Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasivenessBioEssays, 1993
- Effective activation of the proenzyme form of the urokinase‐type plasminogen activator (pro‐uPA) by the cysteine protease cathepsin LFEBS Letters, 1992
- Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer.1991
- UROKINASE-PLASMINOGEN ACTIVATOR, A NEW AND INDEPENDENT PROGNOSTIC MARKER IN BREAST-CANCER1990
- Tumor-associated alpha-2-macroglobulin in human melanomasInternational Journal of Cancer, 1988